KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024

SALT LAKE CITY, UT / ACCESSWIRE / August 26, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that KindlyMD CEO, Tim Pickett, will participate in H.C. Wainwright's 26th Annual Global Investment Conference being held at the Lotte New York Palace Hotel in New York City on September 9-11, 2024.

Mr. Pickett will present virtually, as well as take part in one-on-one investor meetings during the conference.

H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9-11, 2024
Time: Presentation available on demand from 7:00 a.m. ET
Location: Lotte New York Palace Hotel, New York
Speaker: Tim Pickett, CEO
Webcast: https://journey.ct.events/view/c4d3d1ce-2ac4-43a6-ac75-8ff358a8f3d9

To schedule a one-on-one investor meeting with Mr. Pickett, please contact your H.C. Wainwright representative or KCSA Strategic Communications at KindlyMD@KCSA.com.

A replay of this presentation will be available for at least 90 days following the date of the presentation on the Company's website at https://investors.kindlymd.com/events-presentations.

About KindlyMD

KindlyMD™️ is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.

For more information, please visit www.kindlymd.com.

Investor Relations Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com

SOURCE: KindlyMD, Inc



View the original press release on accesswire.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.